Perspective Therapeutics (CATX) Assets (2011 - 2026)
Perspective Therapeutics recorded quarterly Assets of $410.8 million in Q1 2026, up 53.86% quarter-over-quarter from $267.0 million in Q4 2025, and up 24.72% year-over-year from $329.3 million in Q1 2025.
Perspective Therapeutics' Assets history runs 16 years deep, the most recent figure standing at $410.8 million for Q1 2026.
- In Q1 2026, Assets rose 24.72% year-over-year to $410.8 million; the TTM figure through Mar 2026 stood at $410.8 million (up 24.72% YoY), while the FY2025 annual figure was $267.0 million, down 21.73% from the prior year.
- Assets came in at $410.8 million for Q1 2026 at Perspective Therapeutics, up from $267.0 million in the prior quarter.
- In the past five years, Assets ranged from a high of $410.8 million in Q1 2026 to a low of $58.1 million in Q4 2022.
- A 5-year average of $218.6 million and a median of $267.0 million in 2025 frame the typical range for Assets.
- Across the five-year window, Assets jumped 253.93% in 2024 and slipped 24.63% in 2025, its largest moves.
- Perspective Therapeutics' Assets stood at $58.1 million in 2022, then jumped by 68.51% to $97.9 million in 2023, then soared by 248.45% to $341.1 million in 2024, then dropped by 21.73% to $267.0 million in 2025, then soared by 53.86% to $410.8 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $410.8 million, $267.0 million, and $294.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | 410.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 410.77 Mn |
| Dec 31, 2025 | 266.97 Mn |
| Sep 30, 2025 | 294.83 Mn |
| Jun 30, 2025 | 310.73 Mn |
| Mar 31, 2025 | 329.35 Mn |
| Dec 31, 2024 | 341.10 Mn |
| Sep 30, 2024 | 391.15 Mn |
| Jun 30, 2024 | 385.92 Mn |
| Mar 31, 2024 | 278.29 Mn |
| Dec 31, 2023 | 97.89 Mn |
| Sep 30, 2023 | 110.52 Mn |
| Jun 30, 2023 | 120.15 Mn |
| Mar 31, 2023 | 127.65 Mn |
| Dec 31, 2022 | 58.09 Mn |
| Sep 30, 2022 | 62.54 Mn |
| Jun 30, 2022 | 64.44 Mn |
| Mar 31, 2022 | 66.11 Mn |
| Dec 31, 2021 | 67.25 Mn |
| Sep 30, 2021 | 68.71 Mn |
| Jun 30, 2021 | 70.42 Mn |
| Mar 31, 2021 | 71.28 Mn |
| Dec 31, 2020 | 15.51 Mn |
| Sep 30, 2020 | 8.03 Mn |
| Jun 30, 2020 | 8.70 Mn |
| Mar 31, 2020 | 8.96 Mn |
| Dec 31, 2019 | 8.93 Mn |
| Sep 30, 2019 | 10.12 Mn |
| Jun 30, 2019 | 9.42 Mn |
| Mar 31, 2019 | 10.58 Mn |
| Dec 31, 2018 | 11.91 Mn |
| Sep 30, 2018 | 13.34 Mn |
| Jun 30, 2018 | 7.46 Mn |
| Mar 31, 2018 | 8.32 Mn |
| Dec 31, 2017 | 9.38 Mn |
| Sep 30, 2017 | 10.78 Mn |
| Jun 30, 2017 | 12.27 Mn |
| Mar 31, 2017 | 13.94 Mn |
| Dec 31, 2016 | 14.99 Mn |
| Sep 30, 2016 | 16.69 Mn |
| Jun 30, 2016 | 18.10 Mn |
| Mar 31, 2016 | 19.80 Mn |
| Dec 31, 2015 | 20.74 Mn |
| Jun 30, 2015 | 23.00 Mn |
| Jun 30, 2014 | 26.55 Mn |
| Mar 31, 2014 | 27.20 Mn |
| Dec 31, 2013 | 8.19 Mn |
| Sep 30, 2013 | 9.33 Mn |
| Jun 30, 2013 | 7.06 Mn |
| Mar 31, 2013 | 7.89 Mn |
| Dec 31, 2012 | 8.72 Mn |
| Sep 30, 2012 | 9.66 Mn |
| Jun 30, 2012 | 7.51 Mn |
| Mar 31, 2012 | 7.59 Mn |
| Dec 31, 2011 | 8.45 Mn |
| Sep 30, 2011 | 7.02 Mn |
| Jun 30, 2011 | 7.89 Mn |